'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Bharat Parenterals Limited
BPLPHARMA (NSE) · BPLPHARMA (BSE 541096) · ISIN INE365Y01019 · Pharmaceuticals · Est. 1992 · listed 2026 · website
Not on any surveillance list
In Q2 FY27 (quarter to 30 September 2026, consolidated), revenue was ₹136.28 cr and profit after tax ₹11.82 cr. Revenue was 110.9% higher than in Q2 FY26.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 consolidated | ₹136.28 cr | ₹11.82 cr | 17.15 | 29 Oct 2026 |
| Q1 FY27 consolidated | ₹93.74 cr | −₹3.56 cr | −5.17 | 5 Aug 2026 |
| Q4 FY26 consolidated | ₹99.62 cr | −₹8.16 cr | −11.84 | 18 May 2026 |
| Q3 FY26 consolidated | ₹65.19 cr | −₹9.67 cr | −14.03 | 30 Jan 2026 |
| Q2 FY26 consolidated | ₹64.62 cr | −₹8.61 cr | −14.00 | 10 Jan 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹410.82 cr | ₹33.63 cr | ₹557.15 cr |
| 31 Mar 2026 standalone | ₹402.34 cr | ₹20.07 cr | ₹519.94 cr |
| 30 Sep 2025 standalone | ₹398.89 cr | ₹18.29 cr | ₹498.67 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 67.20% | 0.11% | 1.29% | 32.80% |
Latest filings
- Audio Recording of Q2FY27 Earnings Conference Call. 30 October 2026 · BSE
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 29 October 2026 · BSE
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 29 October 2026 · BSE
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 29 October 2026 · BSE
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 29 October 2026 · BSE
Other companies in Pharmaceuticals
- Sun Pharmaceutical Industries Limited
- Lupin Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Mankind Pharma Limited
- Aurobindo Pharma Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 30 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.